AGIO
Price
$37.25
Change
+$0.07 (+0.19%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
2.22B
14 days until earnings call
Intraday BUY SELL Signals
TPST
Price
$0.52
Change
-$0.00 (-0.00%)
Updated
Oct 22 closing price
Capitalization
8.82M
13 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AGIO vs TPST

AGIO vs TPST Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AGIO vs. TPST commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a StrongBuy and TPST is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AGIO with price predictions
Oct 21, 2026

AGIO in upward trend: price rose above 50-day moving average on October 19, 2026

AGIO moved above its 50-day moving average on October 19, 2026 date and that indicates a change from a downward trend to an upward trend. In 46 of 54 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on AGIO as a result. In 82 of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.

The Moving Average Convergence Divergence (MACD) for AGIO just turned positive on October 19, 2026. Looking at past instances where AGIO's MACD turned positive, the stock continued to rise in 41 of 51 cases over the following month. The odds of a continued upward trend are 80%.

Following a +6.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where AGIO advanced for three days, in 229 of 298 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AGIO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

AGIO broke above its upper Bollinger Band on October 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AGIO entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.163) is normal, around the industry mean (2.988). P/E Ratio (-5.304) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (19.685) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. AGIO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AGIO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for TPST with price predictions
Oct 21, 2026

TPST's RSI Oscillator is sitting in oversold zone for 5 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

TPST may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TPST as a result. In 72 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for TPST turned negative on September 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 39 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

TPST moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TPST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for TPST entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-8.093) is normal, around the industry mean (2.988). P/E Ratio (-0.142) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. TPST’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TPST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
AGIO vs TPST: Fundamental Ratings
AGIO
TPST
OUTLOOK RATING
1..100
3391
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
16
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
4193
P/E GROWTH RATING
1..100
9910
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TPST's Valuation (16) in the Pharmaceuticals Major industry is in the same range as AGIO (25) in the Biotechnology industry. This means that TPST’s stock grew similarly to AGIO’s over the last 12 months.

TPST's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as AGIO (100) in the Biotechnology industry. This means that TPST’s stock grew similarly to AGIO’s over the last 12 months.

AGIO's SMR Rating (97) in the Biotechnology industry is in the same range as TPST (100) in the Pharmaceuticals Major industry. This means that AGIO’s stock grew similarly to TPST’s over the last 12 months.

AGIO's Price Growth Rating (41) in the Biotechnology industry is somewhat better than the same rating for TPST (93) in the Pharmaceuticals Major industry. This means that AGIO’s stock grew somewhat faster than TPST’s over the last 12 months.

TPST's P/E Growth Rating (10) in the Pharmaceuticals Major industry is significantly better than the same rating for AGIO (99) in the Biotechnology industry. This means that TPST’s stock grew significantly faster than AGIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGIOTPST
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
75%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
89%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (AGIO: $37.18 vs. TPST: $0.52)
Brand notoriety: AGIO and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 97% vs. TPST: 14%
Market capitalization -- AGIO: $2.22B vs. TPST: $8.82M
AGIO [@Biotechnology] is valued at $2.22B. TPST’s [@Biotechnology] market capitalization is $8.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 1 FA rating(s) are green while TPST’s FA Score has 2 green FA rating(s).

  • AGIO’s FA Score: 1 green, 4 red.
  • TPST’s FA Score: 2 green, 3 red.
According to our system of comparison, both AGIO and TPST are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 4 TA indicator(s) are bullish while TPST’s TA Score has 3 bullish TA indicator(s).

  • AGIO’s TA Score: 4 bullish, 5 bearish.
  • TPST’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AGIO is a better buy in the short-term than TPST.

Price Growth

AGIO (@Biotechnology) experienced а +20.05% price change this week, while TPST (@Biotechnology) price change was -17.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

Reported Earning Dates

AGIO is expected to report earnings on Nov 05, 2026.

TPST is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
AGIO
Daily Signal:
Gain/Loss:
TPST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

AGIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGIO has been loosely correlated with AXON. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AGIO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGIO
1D Price
Change %
AGIO100%
+1.47%
AXON - AGIO
45%
Loosely correlated
+2.54%
NRIX - AGIO
45%
Loosely correlated
-0.31%
TPST - AGIO
40%
Loosely correlated
-9.13%
VCYT - AGIO
38%
Loosely correlated
+3.19%
CNTN - AGIO
37%
Loosely correlated
+11.56%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WW14.200.77
+5.73%
WW International Inc
MLAB129.204.04
+3.23%
Mesa Laboratories
EXPO73.150.60
+0.83%
Exponent
MKL1871.94-12.16
-0.65%
Markel Group
RMCF0.90-0.02
-2.17%
Rocky Mountain Chocolate Factory